Improvement of Facial Nerve Monitoring in Parotid Surgery by Sugammadex

NCT02314234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-02-25

No results posted yet for this study

Summary

To investigate the effectiveness of rapid reversal of rocuronium-induced neuromuscular block by sugammadex during IONM of facial nerve during parotid surgery

Conditions

  • Injury to Nerve During Surgery

Interventions

DRUG

sugammadex (Bridion)

single dose of sugammadex at skin incision

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02314234 on ClinicalTrials.gov